Analysis Life Sciences Thank You Workshop addresses oncology dose optimization across full span of development
Agency IQ
FEBRUARY 23, 2024
On the first day, discussants looked at how to tackle first-in human trials, weighed the importance of the maximum tolerated dose, and looked at the evolving concept of the clinical utility index. This has spawned a movement focused on optimizing dose selection in oncology drug development.
40 
Let's personalize your content